drugset / Trial / NCT02444767
Bimatoprost Ocular Insert Pharmacokinetic Study
NaSingle-groupOpen-labelBasic science
Summary
The Bimatoprost Ocular Insert is intended to provide sustained delivery of bimatoprost to the ocular surface to lower the intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. This study will evaluate the pharmacokinetic aspects of the Bimatoprost Ocular Insert in healthy (non-glaucoma) subjects.
Timeline
- Start
- 2015-03
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | 13 mg | Other |
Indications
No indication recorded.